NCT02519374|Completed
Fiber Tolerability in Children
FITIC
Loading search results
FITIC
Sponsor study identifier
interventional
40
2 countries
2
Study Start
June 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2015
Actual (reported)Study Completion
August 2015
Actual (reported)Assessment of the digestive tolerability of the PROMITOR® .
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2015
Date type not reportedThis date has not been verified as actual or estimated.
June 8, 2015
Actual (reported)July 2015
Actual (reported)August 2015
Actual (reported)August 10, 2015
Actual (reported)Assessment of the digestive tolerability of the Investigational Product (abdominal pain)
Using analog visual scale
7 days of intake
Assessment of the digestive tolerability of the Investigational Product (rumbling)
Using analog visual scale
7 days of intake
Assessment of the digestive tolerability of the Investigational Product (bloating)
Using analog visual scale
7 days of intake
Assessment of the digestive tolerability of the Investigational Product (flatulence)
Using analog visual scale
7 days of intake
Assessment of the digestive tolerability of the Investigational Product (stools consistency & frequency)
Using analog visual scale
7 days of intake
Placebo
Investigational product dose 1
Investigational product dose 2
Investigational product dose 1
Biofortis
Saint-Herblain, 44800, France
Metabolic Unit, Clinical Development Unit Nestec
Lausanne, 1000, Switzerland
40 participants (actual enrollment reported by the registry).
First Submitted
June 8, 2015
First Posted
August 10, 2015
Study Start
June 2015
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms
Investigational product dose 3
Investigational product dose 2
Investigational product dose 3
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
July 2015
Actual (reported)Study Completion
August 2015
Actual (reported)Last Updated
February 5, 2016
Record last verified: 2015-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: